For therapeutic doses of irbesartan in humans, the hyperplasia/ hypertrophy of the renal juxtaglomerular cells does not appear to have any relevance.
Irbesartaani terapeutilised annused inimesel ei paista omavat jukstaglomerulaarrakkude hüperplaasiale/ hüpertroofiale mingit tähendust.